BioSpace News Archive

Drug Development

Chipscreen Biosciences’ Innovative Anti-Tumor Drug CS231295 Tablets: Investigational New Drug (IND) Application Accepted

October 17, 2024
·
3 min read
FDA

Avadel Pharmaceuticals Announces FDA Approval of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension (CIII) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Patients 7 Years of Age and Older with Narcolepsy

October 17, 2024
·
11 min read
News

Rapafusyn Pharmaceuticals to Present In Vivo Data on ENT1 Inhibitor for Acute Kidney Injury at the American Society for Nephrology (ASN Kidney Week 2024)

October 17, 2024
·
2 min read
News

ClearB Therapeutics Announces License and Collaboration With Adjuvance Technologies to Access a Novel Saponin Adjuvant, TQL-1055, and Upcoming Poster Presentations of Pre-Clinical Chronic Hepatitis B Data at AASLD 2024

October 17, 2024
·
3 min read
Drug Development

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS

October 17, 2024
·
4 min read
Business

Seer to Report Third Quarter 2024 Financial Results on November 6, 2024

October 17, 2024
·
1 min read
Business

Anika Announces Third Quarter 2024 Results Conference Call Date

October 17, 2024
·
1 min read
Business

Vir Biotechnology to Provide Business Update and Report Third Quarter 2024 Financial Results on October 31, 2024

October 17, 2024
·
1 min read
Business

TuHURA Biosciences Completes Merger Transaction with Kintara Therapeutics

October 17, 2024
·
8 min read
Business

Acadia Pharmaceuticals to Announce Third Quarter Financial Results on November 6, 2024

October 17, 2024
·
1 min read